B2B pricing strategy for Series A companies: the 90-day install for industrial manufacturing in emerging markets
The exact 90-day plan for standing up B2B pricing strategy at Series A — the point where the founder can no longer be every function. Written for COOs and heads of commercial for mid-market industrial manufacturers in emerging markets.
This edition of the Growth Broker playbook is written for COOs and heads of commercial for mid-market industrial manufacturers operating in emerging markets. In this market, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint, so the way you install B2B pricing strategy has to be shaped to that reality from day one.
Series A is the moment B2B pricing strategy stops being optional. The founder has to step out of some of the work, the plan requires a defensible growth number, and every quarter compounds toward the next raise.
Day 1 to 30: diagnosis and instrumentation. Name the constraint, write the ICP, wire net revenue retention into the board pack.
Day 31 to 60: first live cycle at 20% of planned volume. Founder still in every review. Kill criteria written and enforced.
Inside industrial manufacturing, the binding constraint is almost always distribution and account access, not product, and in emerging markets it is compounded by the fact that operating footprint and pricing fit, not brand awareness is what actually gates growth. B2B pricing strategy is only useful here when it is pointed at both constraints at once.
Day 61 to 90: ramp to full volume, hire the first dedicated operator, and hand off ops. Founder retains strategy and the weekly review.
By day 90 the metric is legible and the trajectory is defensible. This is what turns a Series A story into a Series B round.
Trap most Series A companies fall into: matching a competitor instead of pricing to value. It usually shows up around day 45 when the founder tries to hire ahead of the model.
The Series A version of B2B pricing strategy looks small compared to what you will build at Series B. That is the point — it is a foundation, not a monument.
Concretely for industrial manufacturing in emerging markets: a single named-account win in industrial pays back the program many times over, and the teams that install this early own the category before Western vendors even show up. That is the reason it is worth installing B2B pricing strategy deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Pricing · manufacturing · emerging markets — answered
- Does B2B pricing strategy work for industrial manufacturing in emerging markets?
- Yes — provided it is pointed at distribution and account access, not product and adapted to the fact that in emerging markets, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint. A single named-account win in industrial pays back the program many times over.
- Should we start B2B pricing strategy before Series A?
- Yes if the founder has time; the Series A version is the same model at higher spend.
- How much of the round should fund B2B pricing strategy?
- Meaningful — often 20–30% of the growth line — but only after diagnosis.
- When do we hire the first B2B pricing strategy operator?
- Around day 60, once the model has run one full cycle with the founder.
- What Series A trap should we avoid?
- Matching a competitor instead of pricing to value — usually a premature senior hire.
- What is the emerging markets-specific pitfall when running B2B pricing strategy for manufacturing?
- Importing a playbook that was built for another market. In emerging markets, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint — the install has to reflect that.
Growth Broker editorial
Filed under pricing · manufacturing · emerging markets